Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$35.9M | -- | 18.12% | -- | $0.2500 |
|
ACB.TO
Aurora Cannabis, Inc.
|
$86.5M | -$0.03 | 4.79% | -91.67% | $7.80 |
|
CRON.TO
Cronos Group, Inc.
|
$51.3M | -$0.07 | 33.92% | -156.68% | $3.95 |
|
OGI.TO
Organigram Global, Inc.
|
$73M | -$0.01 | 71.72% | -80% | $3.40 |
|
TSND.TO
Terrascend Corp.
|
$92M | -$0.03 | -12.43% | -74.49% | $1.74 |
|
WEED.TO
Canopy Growth Corp.
|
$71.8M | -$0.11 | -5.09% | -95.48% | $3.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$0.1500 | $0.2500 | $202.3M | 4.92x | $0.00 | 0% | 1.50x |
|
ACB.TO
Aurora Cannabis, Inc.
|
$6.37 | $7.80 | $360.4M | 116.20x | $0.00 | 0% | 0.97x |
|
CRON.TO
Cronos Group, Inc.
|
$3.75 | $3.95 | $1.4B | 28.54x | $0.00 | 0% | 7.80x |
|
OGI.TO
Organigram Global, Inc.
|
$2.64 | $3.40 | $355M | 129.47x | $0.00 | 0% | 1.31x |
|
TSND.TO
Terrascend Corp.
|
$1.00 | $1.74 | $305.5M | -- | $0.00 | 0% | 0.77x |
|
WEED.TO
Canopy Growth Corp.
|
$1.84 | $3.76 | $629.6M | -- | $0.00 | 0% | 1.20x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
27.67% | -1.082 | 33.75% | 1.03x |
|
ACB.TO
Aurora Cannabis, Inc.
|
15.87% | 1.055 | 19.86% | 1.52x |
|
CRON.TO
Cronos Group, Inc.
|
0.16% | 1.773 | 0.16% | 20.73x |
|
OGI.TO
Organigram Global, Inc.
|
2.45% | 2.654 | 2.31% | 1.21x |
|
TSND.TO
Terrascend Corp.
|
73.06% | 5.012 | 98.87% | 0.71x |
|
WEED.TO
Canopy Growth Corp.
|
26.05% | 4.059 | 38.43% | 4.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$8.8M | -$4.1M | 22.71% | 34.07% | -10.27% | $8.3M |
|
ACB.TO
Aurora Cannabis, Inc.
|
-$8M | -$56M | -9.13% | -10.69% | -61.96% | -$46.7M |
|
CRON.TO
Cronos Group, Inc.
|
$24.8M | -$6.9M | 3.71% | 3.71% | -13.83% | $12.4M |
|
OGI.TO
Organigram Global, Inc.
|
$416K | -$28M | -6.89% | -7.06% | -35.03% | -$554K |
|
TSND.TO
Terrascend Corp.
|
$44.7M | $15.3M | -14.74% | -38.6% | 17.11% | $620.3K |
|
WEED.TO
Canopy Growth Corp.
|
$16.9M | -$16.4M | -39.84% | -68.7% | -24.59% | -$19.4M |
Aurora Cannabis, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -58.83%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
22.15% | $0.01 | $238.5M |
|
ACB.TO
Aurora Cannabis, Inc.
|
-8.86% | -$0.91 | $667.4M |
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 20.56%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Aurora Cannabis, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1 | 0 | 0 |
|
ACB.TO
Aurora Cannabis, Inc.
|
2 | 2 | 0 |
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 0.97x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1.50x | 4.92x | $39.9M | $20.5M |
|
ACB.TO
Aurora Cannabis, Inc.
|
0.97x | 116.20x | $90.4M | -$53.2M |
Cronos Group, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of 77.94%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Cronos Group, Inc.'s return on equity of 3.71%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
22.15% | $0.01 | $238.5M |
|
CRON.TO
Cronos Group, Inc.
|
49.47% | $0.09 | $1.6B |
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 5.33%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Cronos Group, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1 | 0 | 0 |
|
CRON.TO
Cronos Group, Inc.
|
1 | 1 | 0 |
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Cronos Group, Inc. quarterly revenues of $50.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Cronos Group, Inc.'s PE ratio is 28.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 7.80x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1.50x | 4.92x | $39.9M | $20.5M |
|
CRON.TO
Cronos Group, Inc.
|
7.80x | 28.54x | $50.1M | $39M |
Organigram Global, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -47.42%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Organigram Global, Inc.'s return on equity of -7.06%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
22.15% | $0.01 | $238.5M |
|
OGI.TO
Organigram Global, Inc.
|
0.52% | -$0.28 | $357.9M |
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Organigram Global, Inc. has an analysts' consensus of $3.40 which suggests that it could grow by 28.79%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1 | 0 | 0 |
|
OGI.TO
Organigram Global, Inc.
|
3 | 1 | 0 |
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Organigram Global, Inc. has a beta of 2.213, suggesting its more volatile than the S&P 500 by 121.273%.
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Organigram Global, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Organigram Global, Inc. pays out -- of its earnings as a dividend.
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Organigram Global, Inc. quarterly revenues of $80.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Organigram Global, Inc.'s net income of -$38M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Organigram Global, Inc.'s PE ratio is 129.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 1.31x for Organigram Global, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1.50x | 4.92x | $39.9M | $20.5M |
|
OGI.TO
Organigram Global, Inc.
|
1.31x | 129.47x | $80.1M | -$38M |
Terrascend Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -15.22%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Terrascend Corp.'s return on equity of -38.6%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
22.15% | $0.01 | $238.5M |
|
TSND.TO
Terrascend Corp.
|
49.87% | -$0.12 | $487.1M |
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 73.79%. Given that Terrascend Corp. has higher upside potential than Auxly Cannabis Group, Inc., analysts believe Terrascend Corp. is more attractive than Auxly Cannabis Group, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1 | 0 | 0 |
|
TSND.TO
Terrascend Corp.
|
4 | 0 | 0 |
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Terrascend Corp.'s net income of -$13.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 0.77x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1.50x | 4.92x | $39.9M | $20.5M |
|
TSND.TO
Terrascend Corp.
|
0.77x | -- | $89.7M | -$13.6M |
Canopy Growth Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -2.46%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Canopy Growth Corp.'s return on equity of -68.7%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
22.15% | $0.01 | $238.5M |
|
WEED.TO
Canopy Growth Corp.
|
25.3% | -$0.01 | $995.3M |
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 104.35%. Given that Canopy Growth Corp. has higher upside potential than Auxly Cannabis Group, Inc., analysts believe Canopy Growth Corp. is more attractive than Auxly Cannabis Group, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1 | 0 | 0 |
|
WEED.TO
Canopy Growth Corp.
|
1 | 4 | 1 |
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Canopy Growth Corp. quarterly revenues of $66.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Canopy Growth Corp.'s net income of -$1.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 1.20x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
1.50x | 4.92x | $39.9M | $20.5M |
|
WEED.TO
Canopy Growth Corp.
|
1.20x | -- | $66.7M | -$1.6M |
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.